Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen

被引:40
作者
Nagendrakumar, Singanallur Balasubramanian [1 ]
Srinivasan, Villuppanoor Alwar [1 ]
Madhanmohan, Muthukrishnan [1 ]
Yuvaraj, Shanmugam [1 ]
Parida, Satya [2 ]
Di Nardo, Antonello [2 ]
Horsington, Jacquelyn [2 ]
Paton, David James [2 ]
机构
[1] Indian Immunol Ltd, Ctr Res & Dev, Foot & Mouth Dis Virus Lab, Hyderabad 500032, Andhra Pradesh, India
[2] Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England
基金
英国生物技术与生命科学研究理事会;
关键词
FMDV; Serology; Relative homology; Cross-protection; Carrier status; ANTIBODIES; ASSAY; DIAGNOSIS; STRAINS; SITES;
D O I
10.1016/j.vaccine.2010.12.127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serology is used to predict vaccine induced protection against challenge with a heterologous strain of the same serotype of foot-and-mouth disease virus (FMDV). To evaluate the accuracy of such predictions, we compared the protection afforded to cattle vaccinated with the O-1 Manisa strain of FMDV against challenge with either a homologous (O-1 Manisa) or a heterologous strain (O-1 Campos). Serology by virus neutralization test (VNT) using O-1 Manisa antiserum predicted an acceptable protection against such a challenge. Two experiments were carried out to compare the results for consistency. A total of 78 nave cattle were vaccinated with different antigen payloads (60-0.94 mu g) of O-1 Manisa. They were challenged by intradermolingual inoculation with live FMDV, either O-1 Manisa or O-1 Campos. Unvaccinated nave control cattle (n=20) were also challenged with either the O-1 Manisa or O-1 Campos viruses and all developed generalized FMD. The protection results for the vaccinated cattle revealed that higher payloads of O-1 Manisa vaccine were needed to protect against heterologous challenge compared to that for homologous challenge. The 50% protective dose (PD50) values for the vaccine in experiments 1 and 2 were found to be 28.78 and 9.44 for the homologous challenge and 3.98 and 5.01 for heterologous challenge. Furthermore, protection against O-1 Campos required a higher level of vaccine-induced antibody against this virus compared to the level of O-1 Manisa neutralizing antibody associated with protection against homologous challenge. The 50% protective level of in vitro neutralizing antibody was found to be log(10) 1.827 for O-1 Campos and log(10) 0.954 for O-1 Manisa based on O-1 Manisa based virus neutralization test. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1906 / 1912
页数:7
相关论文
共 28 条
  • [11] Gardner M., 2000, Statistics with confidence
  • [12] RADIAL IMMUNO-DIFFUSION AND SERUM-NEUTRALIZATION TECHNIQUES FOR ASSAY OF ANTIBODIES TO SWINE VESICULAR DISEASE
    GOLDING, SM
    HEDGER, RS
    TALBOT, P
    WATSON, J
    [J]. RESEARCH IN VETERINARY SCIENCE, 1976, 20 (02) : 142 - 147
  • [13] Article on the collective handling of pharmacological array effort.
    Karber, G
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE, 1931, 162 : 480 - 483
  • [14] RAPID CORRELATION BETWEEN FIELD ISOLATES AND VACCINE STRAINS OF FOOT-AND-MOUTH-DISEASE VIRUS
    KITCHING, RP
    RENDLE, R
    FERRIS, NP
    [J]. VACCINE, 1988, 6 (05) : 403 - 408
  • [15] Reintroduction of foot-and-mouth disease in Argentina:: characterisation of the isolates and development of tools for the control and eradication of the disease
    Mattion, N
    König, G
    Seki, C
    Smitsaart, E
    Maradei, E
    Robiolo, B
    Duffy, S
    León, E
    Piccone, M
    Sadir, A
    Bottini, R
    Cosentino, B
    Falczuk, A
    Maresca, R
    Periolo, O
    Bellinzoni, R
    Espinoza, A
    La Torre, J
    Palma, EL
    [J]. VACCINE, 2004, 22 (31-32) : 4149 - 4162
  • [16] PROTECTIVE IMMUNE-RESPONSE AGAINST FOOT-AND-MOUTH-DISEASE
    MCCULLOUGH, KC
    DESIMONE, F
    BROCCHI, E
    CAPUCCI, L
    CROWTHER, JR
    KIHM, U
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 1835 - 1840
  • [17] *OIE, 2008, MAN STND DIAGN TESTS
  • [18] Selection of foot and mouth disease vaccine strains - a review
    Paton, DJ
    Valarcher, JF
    Bergmann, I
    Matlho, OG
    Zakharov, VM
    Palma, EL
    Thomson, GR
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2005, 24 (03): : 981 - 993
  • [19] Determinants of early foot-and-mouth disease virus dynamics in pigs
    Quan, M
    Murphy, CM
    Zhang, Z
    Alexandersen, S
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2004, 131 (04) : 294 - 307
  • [20] Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus
    Reid, SM
    Grierson, SS
    Ferris, NP
    Hutchings, GH
    Alexandersen, S
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2003, 107 (02) : 129 - 139